Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal

摘要

Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.